BIOMARKERS FOR DIAGNOSIS, PROGNOSIS, PREVENTION, IMPROVEMENT OR RELIEF IN THE TREATMENT OF CHILDHOOD B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

Patent number:

WO22129668

No items found.

The present invention describes the use of lncRNA AL133346.1, optionally combined with mRNAs, for the diagnosis, prognosis, prevention, improvement, relief or treatment of childhood B-cell acute lymphoblastic leukemia, and methods, kits and devices based on said use.

Countries:

Spain

Regions:

Andalusia

Centers:

UNIVERSIDAD DE GRANADA

Other entities:

Sectors:

Health

Subsectors:

Biotechnology

TRL Level:

TRL 2 – technology concept formulated

BRL Level:

PDF Link:

Download here

Video Link:

Watch it here

Sustainable Development Goal:

Applications

Use of lncRNA and mRNA as diagnostic biomarkers for pediatric B-ALL. Support in the therapeutic strategy of patients with pediatric B-ALL. No specific equipment is necessary. Simple method.

Comments

Other related patents

Chemicals

Health

POLYAMINE DERIVATIVES WITH ANTIPARASITIC ACTIVIT

Countries

Spain

Health

Chemicals

Other

PROCEDURE TO CORRECT THE EFFECT OF LIGHT SCATTERING IN FLAT LASER BEAM MICROSCOPE MEASUREMENTS (MACHINE-TRANSLATION BY GOOGLE TRANSLATE, NOT LEGALLY BINDING)

Countries

Spain

Health

AN AZAPYRIDINOPHAN COMPOUND AS AN ANTIFUNGAL

Countries

Spain

Get back to patents directory